JP2002507579A5 - - Google Patents

Download PDF

Info

Publication number
JP2002507579A5
JP2002507579A5 JP2000537569A JP2000537569A JP2002507579A5 JP 2002507579 A5 JP2002507579 A5 JP 2002507579A5 JP 2000537569 A JP2000537569 A JP 2000537569A JP 2000537569 A JP2000537569 A JP 2000537569A JP 2002507579 A5 JP2002507579 A5 JP 2002507579A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
formula
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2000537569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002507579A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP1999/001335 external-priority patent/WO1999048522A1/en
Publication of JP2002507579A publication Critical patent/JP2002507579A/ja
Publication of JP2002507579A5 publication Critical patent/JP2002507579A5/ja
Ceased legal-status Critical Current

Links

JP2000537569A 1998-03-20 1999-03-17 脳組織障害の予防および治療用システインプロテアーゼインヒビター含有医薬組成物 Ceased JP2002507579A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10-72280 1998-03-20
JP7228098 1998-03-20
PCT/JP1999/001335 WO1999048522A1 (en) 1998-03-20 1999-03-17 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment

Publications (2)

Publication Number Publication Date
JP2002507579A JP2002507579A (ja) 2002-03-12
JP2002507579A5 true JP2002507579A5 (enExample) 2006-03-23

Family

ID=13484725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000537569A Ceased JP2002507579A (ja) 1998-03-20 1999-03-17 脳組織障害の予防および治療用システインプロテアーゼインヒビター含有医薬組成物

Country Status (19)

Country Link
US (1) US6342531B1 (enExample)
EP (1) EP1064021B1 (enExample)
JP (1) JP2002507579A (enExample)
KR (1) KR20010041967A (enExample)
CN (1) CN1301173A (enExample)
AR (1) AR018784A1 (enExample)
AT (1) ATE275420T1 (enExample)
AU (1) AU2852699A (enExample)
BR (1) BR9908948A (enExample)
CA (1) CA2324566A1 (enExample)
DE (1) DE69919995T2 (enExample)
ES (1) ES2224613T3 (enExample)
HU (1) HUP0101428A2 (enExample)
ID (1) ID27507A (enExample)
MX (1) MXPA00009188A (enExample)
MY (1) MY133063A (enExample)
NO (1) NO20004679L (enExample)
PL (1) PL342970A1 (enExample)
WO (1) WO1999048522A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7766300A (en) * 1999-10-07 2001-05-10 Novaneuron Inc. Gene necessary for striatal function, uses thereof, and compounds for modulatingsame
JPWO2002034252A1 (ja) 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011850A2 (en) 1990-12-28 1992-07-23 Cortex Pharmaceuticals, Inc. Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
ATE239698T1 (de) 1995-10-25 2003-05-15 Senju Pharma Co Angiogenese hemmer

Similar Documents

Publication Publication Date Title
JP2019094345A5 (enExample)
JP2002527474A5 (ja) 躁病および双極性障害の治療のための医薬
JP2004517087A5 (enExample)
JP2011520792A5 (enExample)
JP2003513073A5 (enExample)
JP2005501120A5 (enExample)
JP2007519649A5 (enExample)
JP2006501295A5 (enExample)
JP2004534816A5 (enExample)
JP2002519425A5 (enExample)
RU2002135312A (ru) Средство, усиливающие секрецию гормона роста
JP2012508251A5 (enExample)
JP2002525323A5 (enExample)
JP2003513071A5 (enExample)
JP2005508872A5 (enExample)
JP2001523716A5 (enExample)
JP2002505297A5 (enExample)
JP2002539089A5 (enExample)
JP2018522915A5 (enExample)
JP2007516292A5 (enExample)
JP2004522781A5 (enExample)
JP2006510659A5 (enExample)
JP2008509210A5 (enExample)
JP2007507472A5 (enExample)
JP2008543821A5 (enExample)